Sarah D de Ferranti
Overview
Explore the profile of Sarah D de Ferranti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
12156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aris I, Rifas-Shiman S, Perng W, Yi L, de Ferranti S, Hivert M, et al.
JAMA Cardiol
. 2024 Dec;
PMID: 39693062
Importance: The American Heart Association put forth the Life's Essential 8 construct to assess cardiovascular health (CVH) based on 8 behavioral and health factors. Few studies have characterized the natural...
2.
Liu J, Bellows B, Jacobs Jr D, Woo J, Urbina E, Balte P, et al.
Circulation
. 2024 Nov;
150(21):1741-1744.
PMID: 39556651
No abstract available.
3.
Zaidi A, Alberts A, Chowdhury D, Beaty C, Brewer B, Chen M, et al.
J Am Heart Assoc
. 2024 Oct;
13(20):e034796.
PMID: 39377195
Background: Lifelong continuity of care is essential for patients with congenital heart disease (CHD) to maximize health outcomes; unfortunately, gaps in care (GIC) are common. Trends in GIC and of...
4.
Johnson J, Hoke C, Chamis A, Campbell M, Gearhart A, de Ferranti S, et al.
J Cardiovasc Magn Reson
. 2024 Aug;
26(2):101086.
PMID: 39181403
"Cases of SCMR" is a case series on the SCMR website (https://www.scmr.org) for the purpose of education. The cases reflect the clinical presentation and the use of cardiovascular magnetic resonance...
5.
Wu F, Mendelson M, Huang Y, Palfrey H, Valente A, Drucker N, et al.
JACC Adv
. 2024 Jun;
1(4):100081.
PMID: 38939714
Background: Atherosclerotic disease is an important cause of morbidity among adults with congenital heart disease (CHD). Prevalence of dyslipidemia in this group is poorly described. Objectives: This study aimed to...
6.
Joynt Maddox K, Elkind M, Aparicio H, Commodore-Mensah Y, de Ferranti S, Dowd W, et al.
Circulation
. 2024 Jun;
150(4):e65-e88.
PMID: 38832505
Background: Cardiovascular disease and stroke are common and costly, and their prevalence is rising. Forecasts on the prevalence of risk factors and clinical events are crucial. Methods: Using the 2015...
7.
Reijman M, Kusters D, Groothoff J, Arbeiter K, Dann E, de Boer L, et al.
Atherosclerosis
. 2024 Apr;
392:117525.
PMID: 38598969
Homozygous familial hypercholesterolaemia is a life-threatening genetic condition, which causes extremely elevated LDL-C levels and atherosclerotic cardiovascular disease very early in life. It is vital to start effective lipid-lowering treatment...
8.
Hammad N, Wolfson J, de Ferranti S, Willett W, Leung C
J Am Heart Assoc
. 2024 Apr;
13(8):e033323.
PMID: 38591328
Background: Food insecurity, a social and economic condition of limited availability of healthy food, is a risk factor for adverse cardiovascular health outcomes among adults; few studies have been conducted...
9.
Zaidi A, Saleeb S, Gurvitz M, Bucholz E, Gauvreau K, Jenkins K, et al.
J Am Heart Assoc
. 2024 Feb;
13(4):e028883.
PMID: 38353239
Background: Gaps in care (GIC) are common for patients with congenital heart disease (CHD) and can lead to worsening clinical status, unplanned hospitalization, and mortality. Understanding of how social determinants...
10.
Zhang Y, de Ferranti S, Moran A
Curr Opin Lipidol
. 2024 Feb;
35(2):93-100.
PMID: 38299384
Purpose Of Review: Despite familial hypercholesterolemia (FH) being the most common genetic cause of cardiovascular disease (CVD), genetic testing is rarely utilized in the US. This review summarizes what is...